CD36 and melanoma: In the spatial regression model comparing the CD36 expression across groups, cells from melanoma SLN (+) were found to have higher odds of expressing CD36 compared to cells from SLN (−) and normal LN (OR = 1.45 and 1.06, respectively), but these comparisons were not statistically significant (Table S3).